US20080275320A1 - Method and device for measurements in blood - Google Patents

Method and device for measurements in blood Download PDF

Info

Publication number
US20080275320A1
US20080275320A1 US12/130,988 US13098808A US2008275320A1 US 20080275320 A1 US20080275320 A1 US 20080275320A1 US 13098808 A US13098808 A US 13098808A US 2008275320 A1 US2008275320 A1 US 2008275320A1
Authority
US
United States
Prior art keywords
light
tubing
signals
detectors
light detectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/130,988
Inventor
Magnus Pettersson
Anna Dahlstrom
Hans Pettersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0203868A external-priority patent/SE0203868D0/en
Priority claimed from SE0203869A external-priority patent/SE0203869D0/en
Application filed by Individual filed Critical Individual
Priority to US12/130,988 priority Critical patent/US20080275320A1/en
Publication of US20080275320A1 publication Critical patent/US20080275320A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14535Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring haematocrit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14557Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted to extracorporeal circuits
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/02Investigating particle size or size distribution
    • G01N15/0205Investigating particle size or size distribution by optical means, e.g. by light scattering, diffraction, holography or imaging
    • G01N15/0211Investigating a scatter or diffraction pattern
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03Cuvette constructions
    • G01N21/05Flow-through cuvettes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/49Scattering, i.e. diffuse reflection within a body or fluid
    • G01N21/53Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke
    • G01N15/01
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03Cuvette constructions
    • G01N2021/0364Cuvette constructions flexible, compressible

Definitions

  • Hematocrit is the concentration of red blood cells (RBC) in blood.
  • RBC red blood cells
  • the measurement of hematocrit values is of great importance in the assessment of the condition of a patient.
  • the established method of measuring hematocrit is by drawing blood from the subject (patient).
  • Various methods to optically measure hematocrit by optical or ultrasonic means have been attempted, e.g., during a dialysis treatment of a patient. In these situations, not only the level of hematocrit is of high importance but also the relative variation of this parameter.
  • the change of the hematocrit or relative blood volume has to be monitored during the treatment.
  • the invention relates to measuring various blood constituents with optical means.
  • Blood is irradiated with—preferably—near infrared or infrared light.
  • Light scattering and attenuation of the light is measured and novel compensations for optical variations in the receptacle walls, flow etc. is used to calculate blood constituents such as hematocrit.
  • the invention makes it possible to add the feature of hematocrit measurement without major alterations into any dialysis system. The addition of this feature makes blood volume measurements at hand.
  • Hematocrit has been measured with various methods since the beginnings of medical diagnosis. Continuous measurement is particularly useful during dialysis treatment. During the process of dialysis, liquids are extracted from the blood stream. As a result, hematocrit increases during the process. For the assurance of good quality in the dialysis treatment, the hematocrit value should be monitored, as this provides the care provider with essential information regarding the rate of extraction of fluids from the patient's bloodstream.
  • a new method and a novel apparatus are presented to measure blood properties with a procedure comprising a new optical probe arrangement that overcomes the problem of the prior art, as for instance optical variations, such as optical density, refractions etc.
  • the invention may even take the shape of a clamp that with great ease can be applied on a transparent tubing such as transport tubing in dialysis.
  • the new probe makes hematocrit values available with unsurpassed precision in the art, in spite of the fact that it measures through transparent tubing that vary in thickness and shape.
  • the blood is measured as it flows through a transparent tubing.
  • a beam of light for instance from a laser is directed perpendicular into the tube and two sensors opposed to each other and perpendicular to the light beam pick up light and the sensor signals are used for the evaluation.
  • the light source and the sensors may lie in the same plane but the plane of the sensors may also be slightly offset in relation to the light beam, for instance along the tubing.
  • a third sensor may be added to each pair, this third sensor being placed close to the light source.
  • the sensor offset in relation to the light source may advantageously be so large that the sensing sectors of the two sensors do not intersect the light beam. With increasing offset the sensitivity to relative changes is increased, whereas a smaller offset will provide a more accurate absolute measurement of the hematocrit value. It is thus possible to use one set of sensors to establish an absolute value and then use a set of more offset placed sensors for the monitoring and controlling of the level during dialysis.
  • FIG. 1 is a cross section of an optical probe arrangement 1 , accommodating light emitting diodes 5 in holes 4 in a framework comprising two halves 2 and 3 suited to fit a receptacle 8 such as tubing for blood 9 .
  • FIG. 2 is a cross section of an optical probe arrangement 1 , accommodating light detectors 6 in holes 4 in a framework comprising two halves 2 and 3 suited to fit a receptacle 8 such as tubing for blood 9 .
  • FIG. 3 depicts the arrangement of the array of light detectors 5 and light emitting diodes 6 on the optical probe arrangement 1 . This is a suggestion where the arrays according to FIG. 1 and FIG. 2 are located with indication “A-A” for the light emitting diodes, and “B-B” for the light detectors.
  • FIG. 4 depicts the arrangement of a second array of light detectors 7 .
  • FIG. 5 depicts the optical probe arrangement 1 with the farther embodiment of light emitting diodes 9 , and photo detectors 8 .
  • FIG. 6 depicts the resulting hematocrit values with reference to measurements performed at an accredited clinical laboratory.
  • LED's are arranged in a preferably—but not limited to—perpendicular fashion to each other around a receptacle, such as tubing, for the blood as apparent in FIG. 1 .
  • the light detectors are arranged in a fashion where they similarly are preferably perpendicular to each other according to FIG. 2 , but at a distance longitudinally away from the encirclement by the LED's, as exhibited in FIG. 3 .
  • a second encirclement of light detectors is fitted. The arrangement is apparent in FIG. 4 .
  • LED and photo detector arrangement should for best understanding be viewed as groups of LED's and photo detectors: For instance, LED 5 a, and photo detector 6 b is one group. Another group can be LED 5 b, and photo detector 6 a and 6 c. Note that no LED's and photo detectors are aligned to achieve direct transmitted light. The invention does not make use of directly transmitted light, as often is the case in prior art.
  • a sample of light detected from a group of one or several photo detectors can be taken at any one short instance in time. Another sample can be taken from the same or another group as a second sample.
  • a first sample is taken from a first group comprising LED 5 a, and light detectors 6 b and 6 d
  • a second sample is taken from a second group comprising LED 5 b
  • light detectors 6 a and 6 c
  • a third sample is taken from a third group comprising LED 5 c
  • light detectors 6 b and 6 d
  • a forth sample is taken from a fourth group comprising LED 5 d, and light detectors 6 a and 6 c.
  • a first result is derived from theses four sequentially acquired samples being signal processed.
  • the process can include variations of amplification factors for the signals from the detectors, and also correlation factors between these signals, to further enhance the detection of the blood constituent to be measured.
  • the results make a first result for blood constituents, such as hematocrit.
  • the error occurring from variations in the cross section of the flow pattern in the vessel is reduced.
  • averaging may reduce the effect the vessel wall has on the measurement.
  • the vessel is the extracorporal circuit of a dialysis system.
  • One of the major advancements in the disclosed invention resides in the new possibility to measure hematocrit trough the walls of dialysis extracorporal circuit, namely the so-called transport tubing of the circuit. It is highly advantageous that no special cuvettes or dedicated arrangements to the disposable bloodlines are necessary.
  • two arrays of detectors are employed. Downstream (or upstream) a blood flow in a vessel such as tubing, a second array of detectors is fitted. This is apparent in FIG. 4 .
  • the mathematical signal processing can further enhance the results by including this “second order” of detectors in the process.
  • a second arrangement of LED's and photo detectors including a second array of detectors is fitted. This is exhibited in FIG. 5 .
  • the LED's emits a different wavelength.
  • the results derived from this second array can beneficially be incorporated in a signaling process with the values derived from the aforementioned first array. Such process makes it possible not only to output all parameters from blood constituents, but also let the saturation value influence the input of signals from the first array to the signaling process. This is beneficial, as blood saturation may influence the first results of blood constituents from the first process from the first array.
  • V-shaped groves in blocks may be used to clamp and shape the tubing so that its walls become essentially flat at LEDs and sensors.
  • the sensors may be arranged in small holes with even smaller openings serving as collimators towards the tubing.

Abstract

We present an optical probe arrangement that surrounds blood in a receptacle. It comprises LED's and light detector arranged to overcome the variations when the receptacle is translucent medical tubing and the like. Also, a signal processing algorithm is used to average signals from a plurality of light detectors, to further enhance results when measuring hematocrit. The invention makes it possible to add the feature of hematocrit measurement into dialysis system without major alterations to the dialysis machine or transport tubing.

Description

    CROSS REFERENCE TO RELATED APPLICATION
  • This application is a divisional of U.S. application Ser. No. 10/528,091, filed Mar. 16, 2005.
  • BACKGROUND OF THE INVENTION
  • Hematocrit is the concentration of red blood cells (RBC) in blood. The measurement of hematocrit values is of great importance in the assessment of the condition of a patient. The established method of measuring hematocrit is by drawing blood from the subject (patient). Various methods to optically measure hematocrit by optical or ultrasonic means have been attempted, e.g., during a dialysis treatment of a patient. In these situations, not only the level of hematocrit is of high importance but also the relative variation of this parameter. In order to provide an optimized but still safe dialysis treatment the change of the hematocrit or relative blood volume has to be monitored during the treatment. The attempts to monitor this have so far not resulted in any product that can measure the hematocrit without a special cuvette integrated in the transport tubing. The methods used so far have therefore increased the cost of every dialysis treatments since the transport tubing must be equipped with this single-use cuvette. The invention presented here does not require any special cuvette, instead it provides the possibility to measure the hematocrit, or monitor the change of relative blood volume directly on any standard dialysis transport tubing on the market without increasing the cost of each treatment.
  • TECHNICAL FIELD
  • The invention relates to measuring various blood constituents with optical means. Blood is irradiated with—preferably—near infrared or infrared light. Light scattering and attenuation of the light is measured and novel compensations for optical variations in the receptacle walls, flow etc. is used to calculate blood constituents such as hematocrit. The invention makes it possible to add the feature of hematocrit measurement without major alterations into any dialysis system. The addition of this feature makes blood volume measurements at hand.
  • PRIOR ART
  • Hematocrit has been measured with various methods since the beginnings of medical diagnosis. Continuous measurement is particularly useful during dialysis treatment. During the process of dialysis, liquids are extracted from the blood stream. As a result, hematocrit increases during the process. For the assurance of good quality in the dialysis treatment, the hematocrit value should be monitored, as this provides the care provider with essential information regarding the rate of extraction of fluids from the patient's bloodstream.
  • Various techniques have been presented in the field of optical measurements of hematocrit in blood. Several make use of the scattering effect RBC has on light passing trough blood in a vessel, cuvette or the like. Oppenheimer presents in U.S. Pat. No. 5,601,080 a method to measure the degree of scatter to derive blood constituents.
  • Other patents are U.S. Pat. No. 4,745,279 to Karkar, describing scattering effect of blood in a cuvette. U.S. Pat. No. 6,493,567 to Krivitski et al. describes a measuring instrument using one light emitting diode and one sensor. U.S. Pat. No. 6,064,474 to Wylie et al is another description of a hematocrit measuring method using the scattering effect RBC has on light. However the known methods and devices do not provide a satisfactory precision.
  • THE INVENTION
  • The above objects are in accordance with the invention achieved by emitting light into the blood and then two detectors placed opposite each other are used to execute the measuring.
  • In accordance with the present invention, a new method and a novel apparatus are presented to measure blood properties with a procedure comprising a new optical probe arrangement that overcomes the problem of the prior art, as for instance optical variations, such as optical density, refractions etc. The invention may even take the shape of a clamp that with great ease can be applied on a transparent tubing such as transport tubing in dialysis. The new probe makes hematocrit values available with unsurpassed precision in the art, in spite of the fact that it measures through transparent tubing that vary in thickness and shape.
  • In the practical embodiment of the invention the blood is measured as it flows through a transparent tubing. A beam of light, for instance from a laser is directed perpendicular into the tube and two sensors opposed to each other and perpendicular to the light beam pick up light and the sensor signals are used for the evaluation. The light source and the sensors may lie in the same plane but the plane of the sensors may also be slightly offset in relation to the light beam, for instance along the tubing. One can also consider using several pairs of sensors offset along the tubing and upstream as well as downstream in order to increase precision. Also a third sensor may be added to each pair, this third sensor being placed close to the light source.
  • In this solution the sensor offset in relation to the light source may advantageously be so large that the sensing sectors of the two sensors do not intersect the light beam. With increasing offset the sensitivity to relative changes is increased, whereas a smaller offset will provide a more accurate absolute measurement of the hematocrit value. It is thus possible to use one set of sensors to establish an absolute value and then use a set of more offset placed sensors for the monitoring and controlling of the level during dialysis.
  • Further preferable developments are apparent from the claims and the following description of a preferred embodiment of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a cross section of an optical probe arrangement 1, accommodating light emitting diodes 5 in holes 4 in a framework comprising two halves 2 and 3 suited to fit a receptacle 8 such as tubing for blood 9.
  • FIG. 2 is a cross section of an optical probe arrangement 1, accommodating light detectors 6 in holes 4 in a framework comprising two halves 2 and 3 suited to fit a receptacle 8 such as tubing for blood 9.
  • FIG. 3 depicts the arrangement of the array of light detectors 5 and light emitting diodes 6 on the optical probe arrangement 1. This is a suggestion where the arrays according to FIG. 1 and FIG. 2 are located with indication “A-A” for the light emitting diodes, and “B-B” for the light detectors.
  • FIG. 4 depicts the arrangement of a second array of light detectors 7.
  • FIG. 5 depicts the optical probe arrangement 1 with the farther embodiment of light emitting diodes 9, and photo detectors 8.
  • FIG. 6 depicts the resulting hematocrit values with reference to measurements performed at an accredited clinical laboratory.
  • DESCRIPTION
  • We have achieved very good results by using the following arrangement of light-emitting diodes (LED's) and photo detectors, when assessing hematocrit values. These values correlate very well with laboratory reference values.
  • Four LED's are arranged in a preferably—but not limited to—perpendicular fashion to each other around a receptacle, such as tubing, for the blood as apparent in FIG. 1. The light detectors are arranged in a fashion where they similarly are preferably perpendicular to each other according to FIG. 2, but at a distance longitudinally away from the encirclement by the LED's, as exhibited in FIG. 3. In a further embodiment, a second encirclement of light detectors is fitted. The arrangement is apparent in FIG. 4.
  • The LED and photo detector arrangement should for best understanding be viewed as groups of LED's and photo detectors: For instance, LED 5 a, and photo detector 6 b is one group. Another group can be LED 5 b, and photo detector 6 a and 6 c. Note that no LED's and photo detectors are aligned to achieve direct transmitted light. The invention does not make use of directly transmitted light, as often is the case in prior art.
  • A sample of light detected from a group of one or several photo detectors can be taken at any one short instance in time. Another sample can be taken from the same or another group as a second sample. Preferably, a first sample is taken from a first group comprising LED 5 a, and light detectors 6 b and 6 d, a second sample is taken from a second group comprising LED 5 b, and light detectors 6 a and 6 c, a third sample is taken from a third group comprising LED 5 c, and light detectors 6 b and 6 d, and finally a forth sample is taken from a fourth group comprising LED 5 d, and light detectors 6 a and 6 c. A first result is derived from theses four sequentially acquired samples being signal processed. The process can include variations of amplification factors for the signals from the detectors, and also correlation factors between these signals, to further enhance the detection of the blood constituent to be measured. The results make a first result for blood constituents, such as hematocrit. In this process, the error occurring from variations in the cross section of the flow pattern in the vessel is reduced. Furthermore averaging may reduce the effect the vessel wall has on the measurement. This is highly beneficial if the vessel is the extracorporal circuit of a dialysis system. One of the major advancements in the disclosed invention resides in the new possibility to measure hematocrit trough the walls of dialysis extracorporal circuit, namely the so-called transport tubing of the circuit. It is highly advantageous that no special cuvettes or dedicated arrangements to the disposable bloodlines are necessary. Our process even makes it unnecessary to fit dedicated tubing to the extracorporeal circuit. This feature is considerably cost saving for the health care provider. Fitting the hereby disclosed probe on the transport tubing also has the advantage that the probe is not interfering with the ordinary functions of the dialysis system. Also, it furnishes the highly beneficial possibility to upgrade any already existing dialysis system with measurement of hematocrit, even if it is not prepared for such purpose. Subsequently blood volume changes can be calculated and displayed.
  • In one embodiment of the invention, two arrays of detectors are employed. Downstream (or upstream) a blood flow in a vessel such as tubing, a second array of detectors is fitted. This is apparent in FIG. 4. The mathematical signal processing can further enhance the results by including this “second order” of detectors in the process.
  • In another embodiment of the invention, a second arrangement of LED's and photo detectors, including a second array of detectors is fitted. This is exhibited in FIG. 5. In this embodiment, the LED's emits a different wavelength. This allows limited spectral analysis for further calculation of blood constituents, such as saturation of hemoglobin as known in the art. The results derived from this second array, can beneficially be incorporated in a signaling process with the values derived from the aforementioned first array. Such process makes it possible not only to output all parameters from blood constituents, but also let the saturation value influence the input of signals from the first array to the signaling process. This is beneficial, as blood saturation may influence the first results of blood constituents from the first process from the first array.
  • In the drawings and the above description a transparent blood transporting tubing is shown clamped between two essentially V-shaped profiles in the walls of which the led and sensors are arranged. In an alternative embodiment V-shaped groves in blocks may be used to clamp and shape the tubing so that its walls become essentially flat at LEDs and sensors.
  • In a further embodiment the sensors may be arranged in small holes with even smaller openings serving as collimators towards the tubing.
  • It is not today clear why the invented measuring method and device are so superior in relation to the prior art, one theory could be the offset between sensors and light source. Only light that has been dispersed from the volume of the blood in the path of the light and into the sense sector of the sensor and from this into the sensor will be registered. In other words only light that has been dispersed at least twice will reach the sensor. By arranging source and sensor perpendicularly blood cells in a major part of the tube cross section will have the opportunity to contribute so that the signals from the sensors become a function of the hematocrite value.

Claims (27)

1-3. (canceled)
4. Sensor device for the measuring of the density of a fluid flowing through a transparent tubing, said device comprising an elongate frame sized to fit around the tubing, said frame carrying a light beam emitter facing the tubing, and one or several sensor(s) also facing the vessel and so arranged that its or their sense sectors do not intersect the beam of the light source in the vessel or tubing.
5. Sensor device according to claim 4, wherein the locations of the light source and sensor(s) respectively are separated lengthwise of the frame.
6. Sensor device according to claim 4, wherein two sensors are arranged with their sensing directions perpendicular to the light beam.
7. An optical probe arrangement that surrounds a fluid flowing through an elongate transparent tubing, said optical probe arrangement comprising a frame sized to surround said receptacle in part, said frame supporting at least two sets of light emitters and light detectors, each set comprising one light emitter and at least one detector, each set arranged to transilluminate the fluid at a preferred angle between said light emitter and said light detector—or detectors—of each set, where said angle is at least sufficient to avert direct light from said light emitter to said light detector, for the detection of constituents in said fluid.
8. An optical probe arrangement according to claim 7, comprising four sets of light emitters and two or three light detectors in each set, wherein a light detector represents a detector incorporated in an adjacent set.
9. An optical probe arrangement according to claim 7, wherein the light emitters are arranged as an array to encircle said elongated tubing at longitudinally one location around said tubing's circumference, and the light detectors are arranged to encircle the tubing at a different circumferential location.
10. An optical probe arrangement according to claim 7, wherein a second array of light detectors are longitudinally located at a third location around said tubing's circumference, and the light detectors are arranged to encircle the tubing at that circumferential location.
11. A method for processing signals from sensor devices as claimed in claim 4, including an amplifier for amplifying signals from the sensor devices, which comprises applying a signal processing algorithm on the signals from said sensor devices to calculate density.
12. A method for processing signals from light detectors as claimed in claim 11, which comprises applying a signal processing algorithm on the signals from said light detectors, to detect said constituents.
13. A method according to claim 12, which comprises applying a multi variable analysis of signals from all light detectors engaged in the signaling process.
14. A sensor device as claimed in claim 4, wherein a third array of light sensors is longitudinally located at a fourth location around said tubing's circumference, and the light sensors are arranged to encircle the tubing at that circumferential location and an second array of light beam emitters is longitudinally located at a fifth location around said tubing's circumference, and the light sensors are arranged to encircle the tubing at that circumferential location.
15. A method for processing signals from light sensors as claimed in claim 14, including an amplifier for amplifying signals from the light sensors, which comprises applying a signal processing algorithm on the signals from said light sensors, calculate density.
16-17. (canceled)
18. A method according to claim 11, wherein signals are processed in a time domain.
19. A sensor device according to claim 4, further comprising a system to calculate density, and presenting the data to a display, and/or transferring data to another application.
20. (canceled)
21. Method for the measuring of the density of a fluid flowing in a tube, comprising directing of a light beam into the tube and that two sensors, are used that are opposed to each other.
22. Method according to claim 21, characterized in that light beam and sensor beam(s) are perpendicular to each other.
23. A sensor device as claimed in claim 4, characterized in that the measuring takes place in a tubing that is clamped in a holder with generally V-shaped recesses so that tube is given a substantially square cross section and that light emitters and sensors are arranged at the flat surfaces.
24. A method for processing signals from light detectors as claimed in claim 7, including an amplifier for amplifying signals from the light detectors, which comprises applying a signal processing algorithm on the signals from said light detectors, to detect constituents in the fluid.
25. A method according to claim 24, which comprises applying a multi variable analysis of signals from all light detectors engaged in the signaling process.
26. An optical probe arrangement as claimed in claim 7, wherein a third array of light detectors is longitudinally located at a fourth location around said tubing's circumference, and the light detectors are arranged to encircle the tubing at that circumferential location, and an second array of light emitters longitudinally is located at a fifth location around said tubing's circumference, and the light detectors are arranged to encircle the tubing at that circumferential location.
27. A method for processing signals from light detectors as claimed in claim 26, including an amplifier for amplifying signals from the light detectors, and which comprises applying a signal processing algorithm on the signals from said light detectors, to detect said constituents.
28. A method according to claim 15, wherein signals are processed in a time domain.
29. A method according to claim 24, wherein signals are processed in a time domain.
30. A method according to claim 27, wherein signals are processed in a time domain.
US12/130,988 2002-12-20 2008-05-30 Method and device for measurements in blood Abandoned US20080275320A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/130,988 US20080275320A1 (en) 2002-12-20 2008-05-30 Method and device for measurements in blood

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0203868A SE0203868D0 (en) 2002-12-20 2002-12-20 Method and apparatus for measuring the amount of red blood cells
SE0203869-3 2002-12-20
SE0203869A SE0203869D0 (en) 2002-12-20 2002-12-20 Device is able to measure the amount of red blood cells
SE0203868-5 2002-12-20
US10/528,091 US7420658B2 (en) 2002-12-20 2003-12-18 Method and device for measurements in blood
PCT/SE2003/002013 WO2004057313A1 (en) 2002-12-20 2003-12-18 Method and device for measurements in blood
US12/130,988 US20080275320A1 (en) 2002-12-20 2008-05-30 Method and device for measurements in blood

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/SE2003/002013 Division WO2004057313A1 (en) 2002-12-20 2003-12-18 Method and device for measurements in blood
US10/528,091 Division US7420658B2 (en) 2002-12-20 2003-12-18 Method and device for measurements in blood

Publications (1)

Publication Number Publication Date
US20080275320A1 true US20080275320A1 (en) 2008-11-06

Family

ID=32684367

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/528,091 Expired - Fee Related US7420658B2 (en) 2002-12-20 2003-12-18 Method and device for measurements in blood
US12/130,988 Abandoned US20080275320A1 (en) 2002-12-20 2008-05-30 Method and device for measurements in blood

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/528,091 Expired - Fee Related US7420658B2 (en) 2002-12-20 2003-12-18 Method and device for measurements in blood

Country Status (9)

Country Link
US (2) US7420658B2 (en)
EP (2) EP1579196B1 (en)
JP (1) JP4643273B2 (en)
AT (1) ATE357652T1 (en)
AU (1) AU2003291591A1 (en)
CA (1) CA2501360C (en)
DE (1) DE60312737T2 (en)
ES (1) ES2285200T3 (en)
WO (1) WO2004057313A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160240065A1 (en) * 2015-02-13 2016-08-18 Samsung Display Co., Ltd. Fluid disruption detection apparatus
US10578553B2 (en) 2016-11-29 2020-03-03 Pioneer Corporation Measuring apparatus
US11080119B2 (en) 2017-03-09 2021-08-03 Pioneer Corporation Information processing with failure detection, apparatus and method
US11529078B2 (en) 2016-12-05 2022-12-20 Air Water Biodesign Inc. Fluid evaluation apparatus and method, computer program, and recording medium

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006029899B4 (en) 2006-06-29 2009-06-04 Fresenius Medical Care Deutschland Gmbh Spectroscopic detector and method for the determination of blood and biological markers in liquids
US8577431B2 (en) 2008-07-03 2013-11-05 Cercacor Laboratories, Inc. Noise shielding for a noninvasive device
US8630691B2 (en) 2008-08-04 2014-01-14 Cercacor Laboratories, Inc. Multi-stream sensor front ends for noninvasive measurement of blood constituents
DE102009017304A1 (en) * 2009-04-11 2010-10-21 Fresenius Medical Care Deutschland Gmbh Apparatus and method for measuring a blood component in blood for an extracorporeal blood treatment device
US9322761B2 (en) * 2009-08-13 2016-04-26 Siemens Healthcare Diagnostics Inc. Methods and apparatus for ascertaining interferents and physical dimensions in liquid samples and containers to be analyzed by a clinical analyzer
DE102010007914A1 (en) 2010-02-12 2012-12-27 Fresenius Medical Care Deutschland Gmbh Apparatus and method for monitoring vascular access for extracorporeal blood treatment
EP2561049A4 (en) 2010-04-20 2015-03-11 Origin Oil Inc Systems, apparatuses, and methods for extracting non-polar lipids from an a aqueous algae slurry and lipids produced therefrom
US20120295338A1 (en) * 2011-05-20 2012-11-22 Paul Reep Monitoring systems for biomass processing systems
DE102011108050B9 (en) * 2011-07-21 2013-08-14 Fresenius Medical Care Deutschland Gmbh Device for determining the concentration of a constituent of blood in a hose line and method for detecting a hose line in a clamping unit
DE102011108786A1 (en) 2011-07-29 2013-01-31 Fresenius Medical Care Deutschland Gmbh Method for determining at least one parameter of extracorporeal blood circulation and devices
DE102011114930B3 (en) * 2011-10-06 2012-11-15 Fresenius Medical Care Deutschland Gmbh Device for clamping arterial blood tube in extracorporeal blood circuit of dialysis device to determine e.g. hemoglobin concentration of blood component of patient, has retaining elements moved from clamping position into release position
DE102011119824B4 (en) 2011-12-01 2013-07-04 Fresenius Medical Care Deutschland Gmbh Method and device for determining a blood component
EP2837327B1 (en) * 2012-04-13 2023-10-18 Air Water Biodesign Inc. Fluid assessment device and method
US10690684B2 (en) 2013-05-10 2020-06-23 Majelco Medical, Inc. Apparatus and system for measuring volume of blood loss
WO2014183003A1 (en) 2013-05-10 2014-11-13 University Of Utah Research Foundation Devices, systems, and methods for measuring blood loss
DE102013011495A1 (en) 2013-07-02 2015-01-08 Laser- Und Medizin-Technologie Gmbh, Berlin Method for determining the concentration of a substance in a deformable container
DE102014108630B4 (en) * 2014-06-18 2021-07-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device and method for performing optical measurements on fluid substances in vessels with a longitudinal direction
JP6827634B2 (en) * 2015-02-27 2021-02-10 マッケ カーディオパルモナリー ゲーエムベーハー Fluid flow measurement and bubble detector
WO2017180656A1 (en) 2016-04-11 2017-10-19 Alfred Akerman Apparatus and system for measuring volume of blood loss
US11826545B2 (en) 2016-09-08 2023-11-28 Fresenius Medical Care Holdings, Inc. Optical blood detection system
WO2019033028A1 (en) * 2017-08-10 2019-02-14 Advanced Polymer Monitoring Technologies, Inc., Dba/ Fluence Analytics Devices and methods for characterization and control of biopolymers and synthetic polymers during manufacturing
EP3723608B1 (en) 2017-12-15 2023-10-11 Gastroklenz Inc. Sensor monitoring system for in-dwelling catheter based treatments
MX2021016013A (en) * 2019-06-26 2022-03-11 Gastroklenz Inc Systems, devices, and methods for fluid monitoring.
US11865270B2 (en) * 2020-01-16 2024-01-09 Starling Medical, Inc. Bodily fluid management system

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745279A (en) * 1986-01-02 1988-05-17 American Hospital Supply Corporation Hematocrit measuring apparatus
US5601080A (en) * 1994-12-28 1997-02-11 Coretech Medical Technologies Corporation Spectrophotometric blood analysis
US5838429A (en) * 1996-05-14 1998-11-17 Stockert Instrumente Gmbh Apparatus for measuring physiological parameters of blood guided in an extracorporeal circulatory system
US6064474A (en) * 1998-02-06 2000-05-16 Optical Sensors, Inc. Optical measurement of blood hematocrit incorporating a self-calibration algorithm
US6315955B1 (en) * 1995-04-06 2001-11-13 Delaval International A.B. Method and apparatus for quantitative particle determination in fluids
US6365106B1 (en) * 1999-01-21 2002-04-02 Sysmex Corporation Sheath flow cell and blood analyzer using the same
US6388752B1 (en) * 1999-05-20 2002-05-14 F. Hoffmann-La Roche Ag Optical measurement system for determination of transmitted and scattered radiation
US6493567B1 (en) * 1997-10-14 2002-12-10 Transonic Systems, Inc. Single light sensor optical probe for monitoring blood parameters and cardiovascular measurements
US20030031352A1 (en) * 2001-08-10 2003-02-13 Nelson Alan C. Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with malignancy and disease
US6694157B1 (en) * 1998-02-10 2004-02-17 Daedalus I , L.L.C. Method and apparatus for determination of pH pCO2, hemoglobin, and hemoglobin oxygen saturation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2141553B (en) * 1983-06-14 1987-06-03 Standard Telephones Cables Ltd Scatter cells for photo sensors
JPS6135335A (en) * 1984-07-28 1986-02-19 Canon Inc Particle analyzing device
US5331958A (en) 1992-03-31 1994-07-26 University Of Manitoba Spectrophotometric blood analysis
EP0736767A1 (en) * 1995-04-07 1996-10-09 Ciba-Geigy Ag Optical detection device for analytical measurements of chemical substances
JP3994143B2 (en) * 1995-11-21 2007-10-17 エヌアイアール ダイアグナスティック インク. Pre-test differentiation method and apparatus for rapid spectrophotometry of specimens for hematology analyzers
US6139800A (en) * 1997-06-23 2000-10-31 Luminex Corporation Interlaced lasers for multiple fluorescence measurement
SE9804142D0 (en) * 1998-11-30 1998-11-30 Gambro Ab Method and device for providing a signal
JP2001272403A (en) * 2000-03-23 2001-10-05 Arkray Inc Method for converting blood determination result

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745279A (en) * 1986-01-02 1988-05-17 American Hospital Supply Corporation Hematocrit measuring apparatus
US5601080A (en) * 1994-12-28 1997-02-11 Coretech Medical Technologies Corporation Spectrophotometric blood analysis
US6315955B1 (en) * 1995-04-06 2001-11-13 Delaval International A.B. Method and apparatus for quantitative particle determination in fluids
US5838429A (en) * 1996-05-14 1998-11-17 Stockert Instrumente Gmbh Apparatus for measuring physiological parameters of blood guided in an extracorporeal circulatory system
US6493567B1 (en) * 1997-10-14 2002-12-10 Transonic Systems, Inc. Single light sensor optical probe for monitoring blood parameters and cardiovascular measurements
US6064474A (en) * 1998-02-06 2000-05-16 Optical Sensors, Inc. Optical measurement of blood hematocrit incorporating a self-calibration algorithm
US6694157B1 (en) * 1998-02-10 2004-02-17 Daedalus I , L.L.C. Method and apparatus for determination of pH pCO2, hemoglobin, and hemoglobin oxygen saturation
US6365106B1 (en) * 1999-01-21 2002-04-02 Sysmex Corporation Sheath flow cell and blood analyzer using the same
US6388752B1 (en) * 1999-05-20 2002-05-14 F. Hoffmann-La Roche Ag Optical measurement system for determination of transmitted and scattered radiation
US20030031352A1 (en) * 2001-08-10 2003-02-13 Nelson Alan C. Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with malignancy and disease

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160240065A1 (en) * 2015-02-13 2016-08-18 Samsung Display Co., Ltd. Fluid disruption detection apparatus
US10578553B2 (en) 2016-11-29 2020-03-03 Pioneer Corporation Measuring apparatus
US11529078B2 (en) 2016-12-05 2022-12-20 Air Water Biodesign Inc. Fluid evaluation apparatus and method, computer program, and recording medium
US11080119B2 (en) 2017-03-09 2021-08-03 Pioneer Corporation Information processing with failure detection, apparatus and method

Also Published As

Publication number Publication date
EP1579196B1 (en) 2007-03-21
EP1748292A1 (en) 2007-01-31
JP4643273B2 (en) 2011-03-02
JP2006510902A (en) 2006-03-30
CA2501360C (en) 2014-09-30
DE60312737T2 (en) 2007-12-06
WO2004057313A1 (en) 2004-07-08
US20050243303A1 (en) 2005-11-03
US7420658B2 (en) 2008-09-02
ES2285200T3 (en) 2007-11-16
DE60312737D1 (en) 2007-05-03
CA2501360A1 (en) 2004-07-08
AU2003291591A1 (en) 2004-07-14
EP1579196A1 (en) 2005-09-28
ATE357652T1 (en) 2007-04-15

Similar Documents

Publication Publication Date Title
US20080275320A1 (en) Method and device for measurements in blood
US6493567B1 (en) Single light sensor optical probe for monitoring blood parameters and cardiovascular measurements
US6718190B2 (en) Sensor calibration and blood volume determination
US9849225B2 (en) Self calibrating blood chamber
US6195574B1 (en) Monitoring constituents of an animal organ using discrete radiation
JP2002529174A (en) Apparatus and method for measuring blood parameters
US6746415B1 (en) Method of blood constituent monitoring using improved disposable extracorporeal conduit
JP2003194714A (en) Measuring apparatus for blood amount in living-body tissue
US6090061A (en) Disposable extracorporeal conduit for blood constituent monitoring
EP0979111A1 (en) Optical detection and quantification of microair in blood
JP2004519287A (en) Method for measuring hemoglobin concentration (HGB) in blood in the circuit of a dialysis machine, measuring device and circuit for application of this method
US6069687A (en) Contaminant detector
EP2434952B1 (en) Apparatus and method for spectrophotometric measurements of blood parameters
US20240035948A1 (en) A cell counter and diagnostic device
SE525904C2 (en) Measurement of density of blood cells involves directing light beam into space that is to be investigated
KR20230001038A (en) Device for simultaneous measurement of urine flowmetry and urine chemistry using optics
IT201900017402A1 (en) AN APPARATUS AND A METHOD FOR THE CONTINUOUS MEASUREMENT OF THE CONCENTRATION OF AN ANALYT IN A FLOW OF A BIOLOGICAL FLUID
IL196368A (en) Methods for analyzing semen

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION